Pyrotinib Active Not Recruiting Phase 3 Trials for Metastatic Breast Cancer With HER2 Positive Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02973737A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer